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Abstract
How cell proliferation subsides as cells terminally differentiate remains largely enigmatic, although this phenomenon is
central to the existence of multicellular organisms. Here, we show that GATA-1, the master transcription factor of
erythropoiesis, forms a tricomplex with the retinoblastoma protein (pRb) and E2F-2. This interaction requires a LXCXE motif
that is evolutionary conserved among GATA-1 orthologs yet absent from the other GATA family members. GATA-1/pRb/E2F-
2 complex formation stalls cell proliferation and steers erythroid precursors towards terminal differentiation. This process
can be disrupted in vitro by FOG-1, which displaces pRb/E2F-2 from GATA-1. A GATA-1 mutant unable to bind pRb fails to
inhibit cell proliferation and results in mouse embryonic lethality by anemia. These findings clarify the previously suspected
cell-autonomous role of pRb during erythropoiesis and may provide a unifying molecular mechanism for several mouse
phenotypes and human diseases associated with GATA-1 mutations.
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Introduction
With more than 100 billion red blood cells generated every day,
the erythroid lineage has the largest quantitative output of cell
production in adult mammals. This impressive capability requires a
pattern of cell proliferation closely related to that of embryonic cells
followed by ultimate inhibition of cell division, when terminal
erythroid differentiation is completed. Yet, the putative molecular
pathways that coordinate cell proliferation and erythroid differen-
tiation remain obscure. The transcription factor GATA-1 is
essential for erythroid differentiation as it transactivates all the
known erythroid-specific genes upon binding to specific DNAmotifs
[1,2]. GATA-1 also exerts a repressive action on a subset of genes
[3], and its overexpression inhibits cell proliferation [4,5]. The
cofactor Friend-of-GATA-1 (FOG-1) binds to GATA-1 [6] and
modulates its activity on given target genes, and mice deficient in
either GATA-1 [7,8] or FOG-1 [9] die from severe anemia.
Perturbation of the cell proliferation machinery also commonly
results in lethal fetal anemia, as seen in mice defective in pRb [10–
12], the three cyclins D together [13], more than one E2F members
or Cdk4/6 [14,15]. With respect to the role of pRb in erythropoiesis
during development, conflicting views persist as to its cell-
autonomous (intrinsic) or nonautonomous (extrinsic) nature, the
latter involving the accessory contribution of macrophages [16] or
even the placenta [17] as the primary cause for embryonic lethality.
Yet, other studies support the existence of a cell-autonomous
component for pRb in erythropoiesis, although the underlying
molecular pathways remain unknown [18–21]. Particularly puz-
zling is the phenotypic paradox of mutations of the GATA-1 gene
that result in the synthesis of an N-terminally truncated GATA-1
protein (GATA-1s) [22]. In a family of patients with an inherited
mutation of the GATA-1 gene that results in GATA-1s expression,
a severe anemia occurs [23]. In contrast, patients with the Down
syndrome (trisomy 21) are prone to cellular selection of acquired
somatic GATA-1 mutations that produce GATA-1s and result in
preleukemic myeloproliferative disorders [24].
Here, we provide evidence of a direct physical interaction
between pRb/E2F-2 and GATA-1 and document its physiological
significance. We have also uncovered a potentially novel function
for FOG-1 as a regulator of pRb for the control of cell
proliferation. This direct interplay between GATA-1, FOG-1,
pRb, and E2F sheds a new light on a constellation of mouse
phenotypes and human syndromes that implicate mutations of the
Rb or GATA-1 genes.
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Results
Direct Interaction between GATA-1 and pRb Requires the
Integrity of a LXCXE Motif
By examining the coding sequence of human GATA-1
(hGATA-1), we have identified an LNCME motif located at
amino acid positions 81 to 85. This sequence exactly matches the
consensus LXCXE motif present in many cellular or viral pRb-
binding proteins [25,26]. Peptidic alignment of all known GATA-
1 orthologs shows the presence of the LXCXE or its variant
LXSXE in all species (Figure 1A). Serine is structurally similar to
cysteine but contains a hydroxyl (-OH) group in place of the thiol
(-SH) group. Neither of these two motifs (LXCXE and LXSXE) is
present in any of the other members of the GATA family (i.e.,
GATA-2 to -6; unpublished data). To probe for the functionality
of this putative Rb-binding domain in hGATA-1 in vivo, NIH-
3T3 cells, which do not express GATA-1, were transduced with
retroviral vectors that encode either mGATA-1 or hGATA1.
Cross coimmunoprecipitation (co-IP) analysis with GATA-1 and
pRb (p110) specific antibodies (Abs) confirmed the hypothesis that
pRb is associated with h/mGATA-1 in this reconstituted model
(Figure S1A), thus suggesting that both LXCXE and LXSXE
motifs are functional within the GATA-1 proteins for pRb
binding. To demonstrate that pRb/hGATA-1 interaction is
specifically dependent upon the LNCME motif, NIH-3T3 cells
were transduced with retroviral vectors that express either (1)
hGATA-1, (2) a naturally occurring N-terminally truncated form
of hGATA-1, referred to as hGATA-1s (‘‘s’’ for ‘‘short’’ [24]),
which is initiated at methionine 84 within the LNCM84E motif, or
(3) hGATA-1 bearing two amino acid substitutions within the
LNCME motif (LNCME to LNGMK; referred to as hGATA-
1Rb2) (Figure 1A). Cross co-IP with GATA-1– and pRb-specific
Abs showed that only wild-type (wt) hGATA-1 interacts with pRb,
whereas hGATA-1Rb2 and hGATA-1s do not (Figure 1B), thus
establishing that the LNCME motif in hGATA-1 is required for
direct association of pRb to GATA-1. In all the aforementioned
co-IP experiments, potential immunoglobulin (Ig) artifacts were
ruled out by analyzing IgG isotype controls for all the Abs used
and for each GATA-1 variant expressed, under the same
experimental conditions (Figure S1B).
Molecular Composition of the GATA-1/pRb Complex:
Presence of E2F-2 and Absence of FOG-1
Because pRb activity is regulated by phosphorylation, we
analyzed the pRb phosphorylation status within the GATA-1/
pRb complex in erythroid (UT7) and nonerythroid (NIH3T3)
cells. There are 16 possible CDK phosphorylation sites (Ser/Thr-
Pro motifs) in pRB. By western blot analysis, Rb proteins segregate
into two distinctly clustered groups of migrating bands: the more
slowly migrating correspond to the so-called ‘‘hyperphosphory-
lated’’ forms, whereas the faster migrating are the ‘‘hypopho-
sphorylated’’ forms, without defined species phosphorylated on
specific residues among the 16 always present. Co-IP with an anti–
GATA-1 Ab followed by western blot analysis with an anti-pRb
Ab indicated that only the hypophosphorylated (‘‘p’’) forms of pRb
were involved in the GATA-1/pRb complex, while one could
detect both hypophosphorylated and (‘‘pp’’) hyperphosphorylated
forms of pRb by IP of the original sample with an anti-pRb
antibody (Figure 1B). Because available pRb antibodies are
notoriously fastidious at differentiating hypo- from hyperpho-
sphorylated pRb with optimal clarity, an additional experiment
was performed by means of antibodies to phospho-pRb. Co-IP
was first performed with specific phospho-pRb antibodies (Pser780,
Pser807/811, or Pser795) before resolution by western blot analysis
reacted with a GATA-1 antibody. We found that GATA-1 was
not precipitated under these conditions (Figure 1C).
Because hypophosphorylated pRb is known to bind members of
the E2F family and actively suppress their transcriptional activity,
whereas it has been recently reported that only E2F-2—among all
the E2F members present in end-stage (CD71+, TER119+) fetal
liver erythroid cells—directly interacts with pRb (p110) [20], we
investigated whether E2F-2 is present within the GATA-1/pRb
complex. To this end, we purified CD71+ erythroid cells (.90%
TER119+) from embryonic day (E)12.5 mouse fetal liver. We first
established that all Abs used were efficient and specific by
immunoprecipitation (IP) and western blot analysis and that
signals were not Ig artifacts (IgG isotype controls), especially for
GATA-1 proteins that migrate at levels similar to heavy Ig chains
(50 kDa) (Figure S2B). Results of co-IP experiments demonstrated
that GATA-1, pRb, and E2F-2 do exist as a tricomplex in nuclear
extracts from purified E12.5 mouse fetal liver erythroid cells
(Figure S2C and S2D).
To further characterize the molecular composition of the
GATA-1/pRb/E2F-2 tricomplex, we performed a co-IP assay
with an Ab specific for E2F-2 followed by western blot analysis
reacted with Abs specific for either pRb, GATA-1, or FOG-1, the
known partner of GATA-1. Whereas GATA-1 and pRb proteins
could be identified within the E2F-2 immunoprecipitate, FOG-1
was not found (Figure 1D). As we previously demonstrated that
GATA-1 is directly associated with pRb and that GATA-1 is not
known to bind directly to E2F-2, we can thus surmise that two
pRb complexes can possibly coexist in nuclear extracts from fetal
liver erythroid cells: pRb/E2F-2 and GATA-1/pRb/E2F-2. To
probe whether the presence of E2F-2 is required for GATA-1/
pRb complex formation, we first performed an immunodepletion
of E2F-2 followed by western blot analysis of the unbound fraction
with GATA-1 or pRb specific Abs (Figure S2E). Results indicate
that both GATA-1 and pRb could be detected in the unbound
fraction (Figure 1D and S2D). The E2F-2 immunodepleted
fraction was then submitted to secondary co-IPs with Abs specific
for either pRb, GATA-1, or FOG-1. Secondary IP precipitates
Author Summary
Red blood cell production, or erythropoiesis, proceeds by a
tight coupling of proliferation and differentiation. The
earliest erythroid progenitor identifiable possesses rem-
nant stem cell characteristics as it both self-renews and
differentiates. Each progenitor gives rise to more than
10,000 cells, including secondary progenitors. Yet, during
the next stage of differentiation, much of this renewal
capability is lost, and terminal erythroid differentiation
progresses in a stepwise manner through several stages
separated by a single mitosis. The transcription factor
GATA-1 is essential for erythroid differentiation because it
induces the expression of all the known erythroid-specific
genes. Here, we show that GATA-1 directly interacts with
proteins that are central to the process of cell division: the
retinoblastoma protein pRb and the transcription factor
E2F. Specifically, E2F becomes inactivate after engaging in
a GATA-1/pRb/E2F tricomplex. Another erythroid transcrip-
tion factor, termed FOG-1, is able to displace pRb/E2F from
this complex in vitro upon binding to GATA-1. We
hypothesize that the liberated pRb/E2F can then be the
target of subsequent regulation to ultimately release free
E2F, which triggers cell division. The physiological role of
this new pathway is evidenced by transgenic mouse
experiments with GATA-1 mutants unable to bind pRb/
E2F, which result in embryonic lethality by anemia.
GATA-1 Binding to pRb/E2F
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were resolved by western blot analysis with Abs specific for either
E2F-2, pRb, GATA-1 or FOG-1. An association between pRb
and GATA-1 could not be detected in the E2F-2 unbound fraction
(Figure 1D).
From these series of experiments, we can conclude that (1) a
GATA-1/pRb/E2F-2 tricomplex, in which pRb is hypopho-
sphorylated, is present in late-stage erythroid cells from mouse
fetal livers, (2) the GATA-1 LXCXE motif is required for direct
association of pRb/E2F-2 to GATA-1, (3) GATA-1 and pRb do
not form a bicomplex in the absence of E2F-2, (4) only E2F-2, but
no other form of E2F present in these erythroid cells, allows
measurable GATA-1/pRb/E2F tricomplex formation, and (5)
FOG-1 is excluded from the GATA-1/pRb/E2F-2 tricomplex.
FOG-1 Interferes with the GATA-1/pRb/E2F-2 Association
and Displaces pRb from GATA-1 by Direct Protein–
Protein Interaction
Before addressing the physiological relevance of these findings,
we first probed the apparent paradox that FOG-1 is known to be a
key cofactor of GATA-1 in erythroid cells, whereas we have now
established that FOG-1 is excluded from the GATA-1/pRb/E2F-2
tricomplex. Although the amino acid residues of GATA-1 known to
Figure 1. The GATA-1 LXCXE motif mediates the GATA-1/pRb interaction. (A) Top, protein sequence alignment of GATA-1 orthologs. The
consensus pRb association motif, LXCXE, is boxed. Bottom, protein sequence alignment of GATA-1 mutants used in Figure 2B. (B) Co-IP assays of
nuclear lysates from retrovirally transduced NIH-3T3 cells expressing wt hGATA-1, hGATA-1 bearing two amino acid substitutions that disrupt the
LNCME motif (Rb2), or hGATA-1 lacking 83 NH2 amino acids (S). Corresponding amino acid sequences are indicated at the bottom of Figure 1A. The
initial IP step was performed with either anti(a)-GATA-1 (C-20; Santa Cruz Biotechnology), which recognizes both wt and S forms of GATA-1, or
anti(a)-pRb (BD Pharmingen) Abs. The immunoprecipitates were subsequently resolved by western blot analysis with either one of the same Abs, i.e.,
anti(a)-pRb or anti(a)-GATA-1. Hypo (‘‘p’’) and hyperphosphorylated (‘‘pp’’) pRb forms are indicated. An identical experiment, demonstrating that
signals were not immunoglobulin artifacts (IgG isotype species-specific controls for all the Abs used), is shown in Figure S1B. (C) Co-IPs of nuclear
extracts from the erythroid cell line UT-7 were performed with either (a)-GATA-1 (C20; Santa Cruz Biotechnology) or (a)-pRb (BD Pharmingen) Abs.
Four different anti-pRb Abs were used with different specificities: a-pRb (BD Pharmingen) recognizes all forms of pRb regardless of their
phosphorylation status; the other three Abs recognize pRb phosphorylated on either Ser780, Ser795, or Ser807/811 (Cell Signaling Technology). The
precipitated proteins were subsequently analyzed by western blot using the same pRb Abs or an a-GATA-1 Ab (N1; Santa Cruz Biotechnology). (D) A
first IP of nuclear extracts from purified CD71+ (.90 TER119+) late-stage erythroid cells from E12.5 mouse fetal liver was performed with an a-E2F-2
Ab. The first IP immunoprecipitate was analyzed in lane 3, with its IgG species-specific isotype control (lane 2). The E2F-2 immunodepleted
supernatant was then submitted to secondary IPs with either a-E2F-2 (lane 8), a-pRb (lane 9), a-GATA-1 (lane 10), a-FOG-1 (lane 11), or the negative
control a-Nucleophosmin (Nph) (lane 12) Abs. The relevant IgG species-specific isotype controls are shown in lanes 5, 6, and 7 (see experimental
procedure in Figure S2E). Initial 5% input and 5% supernatant controls were analyzed in lanes 1 and 4, respectively. Primary (a-E2F-2) IP, secondary
IPs, and the aforementioned controls were subsequently resolved by western blot analysis with the indicated Abs (rows a to e).
doi:10.1371/journal.pbio.1000123.g001
GATA-1 Binding to pRb/E2F
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interact with FOG-1 lie within a zinc finger domain located outside
the LNCME motif [27,28], we investigated whether FOG-1 could,
nevertheless, regulate the formation of the tricomplex. To this end,
we generated pure populations of NIH3T3 cells that express
hGATA-1 after retroviral transfer, in which we subsequently
transiently transfected various amounts of a plasmid that expresses
human FOG-1 (hFOG-1). We chose NIH3T3 cells because they
constitutively express E2F proteins, including E2F-2, although they
do not naturally express GATA-1 or FOG-1 in the absence of
transfection. Co-IP assays showed that hFOG-1 was able, in a dose-
dependant manner, to prevent hGATA-1 from forming a complex
with pRb (Figure 2A). To assess whether a direct protein–protein
interaction between GATA-1 and FOG-1 is required to dissociate
pRb from GATA-1, we expressed relevant mutants of hGATA-1
and hFOG-1 in NIH3T3 cells following an identical experimental
approach. We made use of the hGATA-1V205G mutant, which
comprises a point mutation that substitutes a glycine for a valine at
codon 205. This mutation, naturally found in patients and
previously studied in mice, is associated with severe dyserythro-
poietic anemia and thrombocytopenia [28,29]. It was previously
established that this mutation causes the disruption of GATA-1
binding to FOG-1 and, as a consequence, a failure of expression of
genes dependent on GATA-1 for their transactivation as well as the
lack of repression of the c-Myc and GATA-2 genes [30]. We thus
expressed hGATA-1, hGATA-1Rb2, or hGATA-1V205G in NIH-
3T3 cells by retroviral transfer followed by transient transfection of a
plasmid that expresses hFOG-1. Co-IP revealed that hFOG-1 was
unable to dissociate hGATA-1V205G from pRb in contrast to
hGATA-1 (Figure 2B). As a corroborating demonstration, we used a
compensatory hFOG-1 mutant (hFOG-1S706R) that is able to bind
to hGATA-1V205G and rescue the erythroid maturation of GATA-
12/2 cells expressing hGATA-1V205G [30]. Co-IP assays showed
that hFOG-1S706R was able to trigger a partial dissociation of
hGATA-1V205G from pRb (Figure 2B). The residual association of
Figure 2. FOG-1 interferes with GATA-1/pRb association. (A) Co-IPs, by means of an anti(a)-GATA-1 Ab, of nuclear extracts from retrovirally
transduced NIH-3T3 cells expressing hGATA-1 or hGATA-1Rb2 and from the same cells after subsequent transient transfection with increasing
amounts (1- to 5-fold, with 1-fold = 0.1 mg) of a hFOG-1 expression plasmid. We verified that .90% cells were successfully transduced by each of the
retroviral vectors on the basis of coexpression of eGFP from an internal ribosome entry site (IRES). Immunoprecipitates were then resolved by western
blot analysis with either anti(a)-GATA-1 or anti(a)-pRb antibodies, under identical experimental conditions as for Figure 1B and S1. The amount of
hFOG-1 expressed after transient transfection was assessed in parallel on total nuclear extracts with an anti(a)-FOG-1 Ab (left column). (B) Nuclear
extracts were made from retrovirally transduced NIH-3T3 cells expressing hGATA-1, or hGATA-1V205G, which cannot interact with hFOG-1, or 3 d after
transient transfection with a plasmid expressing hFOG-1 or an identical amount of an expression plasmid encoding hFOG-1S706R, which can interact
with hGATA-1V205G. We verified that .90% cells were successfully transduced by each of the retroviral vectors on the basis of coexpression of eGFP
from an IRES. Co-IP assays were performed with these nuclear extracts by means of a-GATA-1 and a-FOG-1 Abs, followed by western blot analysis
with either a-GATA-1, a-FOG-1, or a-pRb Abs. A schematic representation of the various combinations of FOG and GATA variants expressed (lines 1 to
3) is indicated at the bottom of the figure. (C) A proposed protein equilibrium model.
doi:10.1371/journal.pbio.1000123.g002
GATA-1 Binding to pRb/E2F
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hGATA-1V205G to pRb in the presence of hFOG-1S706R is likely to
result from the lower affinity of hFOG-1S706R for hGATA-1V205G
compared to that of hFOG-1 for hGATA-1 (Figure 2B and [30]).
Altogether, we thus conclude that FOG-1 is capable of
displacing pRb/E2F from GATA-1 in vitro by direct GATA-1/
FOG-1 interaction. An equilibrium model between GATA-1,
pRb, E2F-2, and FOG-1 is proposed (Figure 2C).
Cell Proliferation Is Controlled by Differential Association
of GATA-1 to FOG-1 or pRb
As GATA-1 overexpression is known to inhibit cell growth
[4,5], we then set out to study the putative role of the GATA-1/
pRb/E2F complex on cell proliferation. Because erythroid cells
naturally express both GATA-1 and FOG-1, thus making it
difficult to dissect the respective contribution of each of the factors
and to decouple their effects on proliferation per se versus terminal
erythroid cell differentiation, we first chose to establish a
reconstituted cellular model after forced expression of wt and
mutant GATA-1 proteins together with their corresponding FOG-
1 interacting partners in the nonerythroid NIH3T3 cell line. We
monitored, every day for 4 d, the growth of NIH-3T3 cells
transduced with retroviral vectors that express either hGATA-1 or
hGATA-1Rb2. Because hGATA-1 and hGATA-1Rb2 proteins
were expressed at similar levels in transduced cells (Figure 1B) with
undistinguishable transcriptional activity (Figure S3), this assay
becomes relevant. Whereas hGATA-1 expression impaired NIH-
3T3 cell proliferation, as previously reported [5], we found that
hGATA-1Rb2 had no effect on it (Figures 3A and S4). Because
pRb/E2F has been shown to be necessary to the G1/S transition
[25,26], we investigated whether the cellular distribution of phases
of the cell cycle would be altered by the GATA-1/pRb/E2F
association. NIH3T3 cells were transduced with retroviral vectors
constitutively expressing either hGATA-1 or hGATA-1Rb2.
Transduced NIH3T3 (eGFP-positive) cells were then starved in
1% serum (cell synchronization) for 72 h, and cell cycle
progression was studied after stimulation in 10% serum at Day
2. As previously described [5], expression of GATA-1 blocked the
cell cycle at the G1/S transition, whereas hGATA-1Rb2
expression did not (Figure 3B).
To clarify the role of pRb in the observed GATA-1–dependent
impairment of cell growth, we knocked down pRb expression in
the transduced NIH-3T3 cells by transient transfection of a small
interfering RNA (siRNA) directed against pRb. Consistent with
our expectation, GATA-1–mediated inhibition of cell growth was
abrogated for 2 d before cells ultimately stopped proliferating as
the inhibitory effect of the siRNA vanished (Figure S5A). pRb
knock-down by siRNA was concurrently assessed by western blot
analysis, which indicated that complete inhibition of pRb
expression occurred only during the first 2 d after siRNA
transfection (Figure S5B) without interference with the expression
of p107 (Figure S5C). When the same experiment was performed
with the human osteogenic sarcoma SAOS-2 cell line, which does
not express endogenous GATA-1 or pRb, neither retrovirally
expressed hGATA-1 nor hGATA-1Rb2 had an effect on cell
proliferation (Figure S5D). These results together establish that
direct interaction of pRb to GATA-1 through its LXCXE motif is
central to the antiproliferative effect of GATA-1.
We then focused on the putative role of FOG-1 in this process.
NIH-3T3 cells constitutively expressing hGATA-1 after retroviral
transduction were transiently transfected with increasing amounts
of a hFOG-1 expression plasmid and cell proliferation monitored
for 5 d. hFOG-1 relieved the growth inhibitory effect of hGATA-1
for NIH-3T3 cells in a dose-dependent manner (Figure 3C). When
the same experiment was performed with the non–FOG-1–
interacting mutant hGATA-1V205G instead of hGATA-1, hFOG-1
was unable to counteract the inhibition of NIH-3T3 cell
proliferation mediated by hGATA-1V205G at the displacing dose
of FOG-1 established for hGATA-1 (Figure 3D). When hFOG-
1S706R was combined with hGATA-1V205G in a similar experi-
ment, rescue of cell proliferation was observed albeit only partially
(Figure 3D), consistent with the lower affinity of hFOG-1S706R for
hGATA-1V205G compared to that of hFOG-1 for hGATA-1
(Figure 2B and [30]).
To establish the relevance of these finding for erythroid cells, we
made use of the erythroid cell line G1E, which is blocked at the
proerythroblast stage and derives from mouse embryonic stem (ES)
cells with complete biallelic inactivation of the endogenous GATA-1
genes (GATA-12/2) [31]. G1E and NIH3T3 cells were transduced
with retroviral vector constitutively expressing either hGATA1,
hGATA-1Rb2, hGATA-1V205G, or hGATA-1V205GRb2. The
hGATA-1V205G mutant and the double hGATA-1V205GRb2
mutant were included in this study in an effort to decouple effects
on cell proliferation per se versus terminal erythroid cell
differentiation, which is known to be dependant upon GATA-1/
FOG-1 interaction and would here confuse data interpretation since
G1E cells naturally express FOG-1. In agreement with the
conclusion we reached in reconstituted NIH3T3 cells, the various
GATA-1 forms behaved similarly in G1E and NIH3T3 cells (i.e.,
inhibition of cell proliferation with hGATA1 and hGATA-1V205G,
as opposed to maintenance of cell proliferation with hGATA-1Rb2
and hGATA-1V205GRb2) (Figure 4A and 4B). However, the rate of
cell proliferation was lower in the G1E cell population in the
presence of the hGATA-1Rb2 mutant as compared to G1E cells
expressing the double hGATA-1V205GRb2 mutant and NIH3T3
cells expressing either of these single or double mutants, in
agreement with findings discussed in the subsequent section that
the hGATA-1Rb2 mutant induces partial terminal erythroid
differentiation of the G1E cell population through GATA-1/
FOG-1 complex formation. Taken together, these findings establish
a novel function for FOG-1 and point to the role of the GATA-1/
FOG-1 association as a potential molecular rheostat to regulate the
inhibition of cell proliferation induced by GATA-1. However, G1E
cells transduced with a retroviral vector that expresses GATA-1s
hyperproliferate (Figure 4C). This suggests that hGATA-1Rb2, and
hGATA-1s are not functionally equivalent.
Forced Expression of hGATA-1Rb2 Fails to Induce Proper
Terminal Erythroid Differentiation of GATA-12/2 Cells
Since pRb has been implicated in the differentiation processes of
several cell types [16,26], in addition to its role in cell cycle control,
we then investigated whether the interaction between pRb and
GATA-1 is involved in the differentiation of erythroid cells. To this
end, we returned to the erythroid cell line G1E. Retrovirus-
mediated expression of hGATA-1 in G1E cells induced terminal
erythroid differentiation of cells positive for coexpression of vector-
encoded eGFP, as evidenced by May-Gru¨nwald-Giemsa and
benzidine staining for identification and scoring of the various red
blood cell precursors (Figure 5A and 5B). In contrast, forced
expression of hGATA-1Rb2 dramatically altered the distribution of
erythroid precursors towards the more immature elements,
although the initiation of erythroid differentiation was not impaired
(Figure 5A and 5B). The same results were obtained with another
erythroid cell line, referred to as GAK14 (M. Yamamoto,
unpublished data), which was independently developed from mouse
GATA-1.05 ES cells (Figure S6A). To determine more precisely the
cell composition of G1E-transduced (eGFP positive) cells, erythro-
poietic maturation was assessed 6 d after transduction by
cytofluorometry for c-Kit, CD71, and TER119 expression.
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Although the complete loss of c-Kit expression in both hGATA-1–
and hGATA-1Rb2–transduced G1E cells indicated that erythroid
differentiation was initiated normally in either case, quantification
of CD712TER119hi (41% vs. 0%) and CD71hiTER1192 (2% vs.
72%), respectively, showed that terminal erythroid differentiation
was impaired in hGATA-1Rb2 G1E cells (Figure 5C). GATA-
1Rb2 G1E cells were able to progress to an intermediate
(CD71hiTER119lo) stage like hGATA-1 G1E cells (25% vs. 16%,
respectively, Figure 5C), but hGATA-1 G1E cells differentiated
further. A similar conclusion was reached by morphological
identification and scoring of the various red blood cell precursors
of the retrovirally transduced GAK14 cell line (Figure S6B).
To study the potential effects of the interplay between GATA-1,
pRb/E2F, and FOG-1 upon the differentiation of erythroid cells,
we analyzed by flow cytometry the phenotypes of G1E cells
expressing hGATA-1, hGATA-1V205G, or hGATA-1V205GRb2
after retroviral vector transduction (Figure 5C). Whereas hGATA-
1–expressing cells became c-Kit2, CD71+, and TER119+, both
hGATA-1V205G and hGATA-1V205GRb2 expressing cells failed to
express TER119 and continued to express c-Kit. These data
indicate that it is the GATA-1/FOG-1 association, but not the
GATA-1/pRb/E2F complex, which is required for the down-
expression of c-Kit during the early stage of proerythroblast
differentiation.
Figure 3. GATA-1/pRb interaction is required for GATA-1–mediated G1/S phase arrest of cell proliferation, which is antagonized by
FOG-1 in vitro. (A) Retroviral vectors encoding wt hGATA-1 or the hGATA-1 mutant that cannot interact with pRb (hGATA-1Rb2) were used to
transduce NIH-3T3 cells, and proliferation of the eGFP-positive NIH-3T3 cells was monitored each day for 4 d by means of the fluorimetric metabolic
growth indicator Uptiblue (Interchim) (n= 6). Migr indicates NIH3T3 cells transduced with the ‘‘empty’’ retroviral vector (Migr vector), which only
expresses eGFP. We verified that.90% cells were successfully transduced by each of the retroviral vectors on the basis of coexpression of eGFP from
an IRES. (B) Cell cycle analysis of NIH3T3 cells transduced with a retroviral vector (Migr) expressing hGATA-1 or hGATA-1Rb2. Transduced cells were
synchronized during a 72-h culture in the presence of 1% FCS (serum starvation) and subsequently serum stimulated for 48 h in the presence of 10%
FCS. The distribution of cells in G0/G1, S, and G2/M phases was evaluated by measuring their DNA content by cytofluorometry following Hoechst
33342 (Molecular Probes/Invitrogen) staining. The percentage of cells in the different phases of the cell cycle was evaluated as described in Materials
and Methods. (C) NIH-3T3 cells transduced with either an ‘‘empty’’ retroviral vector (Migr) or one that encodes hGATA-1 or hGATA-1Rb2 were
transiently transfected with increasing amounts (1- to 5-fold) of a hFOG-1 expression plasmid and the proliferation of the cells monitored for 5 d by
Uptiblue reagent (Day 0 corresponds to the day of the FOG-1 plasmid transfection). We verified that.90% cells were successfully transduced by each
of the retroviral vectors on the basis of coexpression of eGFP from an IRES. To increase legibility, curves are numbered 1 to 10 as well as represented
with different colors. (D) NIH-3T3 cells, transduced with either an ‘‘empty’’ retroviral vector (Migr) or a retroviral vector that expresses hGATA-1 or
hGATA-1V205G, were transiently transfected with the same amount of hFOG-1 or hFOG-1S706R. We verified that .90% cells were successfully
transduced by each of the retroviral vectors on the basis of coexpression of eGFP from an IRES. Cell proliferation was monitored each day for 5 d by
Uptiblue (Day 0 corresponds to the day of the FOG-1 plasmid transfection). Two independent experiments gave a similar result (n= 6 for each
experiment). To increase legibility, curves are numbered 1 to 7 as well as represented with different colors.
doi:10.1371/journal.pbio.1000123.g003
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Direct Interaction of GATA-1 with pRb Is Necessary for
Terminal Erythropoiesis In Vivo
To assess the putative physiological effects of the protein–
protein interaction between GATA-1 and pRb in a whole animal,
we performed a transgenic complementation rescue assay [32].
Because the GATA-1 gene is located on the X chromosome, which
is randomly inactivated in every cell, neither homozygous GATA-
12/GATA-12 females nor hemizygous GATA-12/Y males are
viable. We thus made use of mice that carry a mutant GATA-1
allele, referred to as GATA-1.05, which expresses only 5% of
GATA-1 wt levels. As previously shown, male GATA-1.05/Y mice
die in utero from impaired hematopoiesis, whereas heterozygous
female mice (GATA-1.05/X) spontaneously recover shortly after
birth from embryonic/fetal and neonatal anemia [32]. In
preparation for crossing experiments with these female mice, we
generated transgenic (Tg) lines of mice that express either
hGATA-1Rb2 or its wt counterpart hGATA-1 under the control
of transcriptional regulatory sequences referred to as GATA-1
hematopoietic regulatory domain (HRD). HRD-driven transcrip-
tion is known to recapitulate the endogenous GATA-1 gene
expression pattern in both primitive and definitive erythroid
lineages of Tg mice [1]. We focused on two of the hGATA-1Rb2–
expressing lines (Tg Lines 2 and 5), because expression of the
hGATA-1Rb2 transgene was at a level equivalent to that of the
endogenous mouse GATA-1 gene (Figure 6A). Mouse Tg line 8
was also analyzed as an example of supraphysiologic expression of
the hGATA-1Rb2 transgene (level 280% that of the endogenous
mouse GATA-1 gene). Males of these Tg mice were then mated
with heterozygous GATA-1.05/X females, and their male progeny,
referred to as 1.05/Y+hGATA-1Rb2 and 1.05/Y+hGATA-1,
studied. The expected and the observed pup numbers of
XGATA-1.05/Y mice harboring the transgene are indicated in
Figure 6B. The first observation we made is that the control
hGATA-1 transgene could fully rescue GATA-1.05/Y male mice
from lethality. Although some of the 1.05/Y+hGATA-1 male
embryos showed a slightly anemic appearance at E13.5, most were
indistinguishable from wt littermate embryos (Figure 6C). Impor-
tantly, their erythropoiesis caught up during late gestation, and
viable pups were born with the expected Mendelian distribution
(15 rescued out of 133 pups). In contrast, 1.05/Y+hGATA-1Rb2
males from either Tg Line 5 (0 rescued out of 45 pups) or Tg Line
2 (0 rescued out of 47 pups) suffered from profound anemia and
small size at E12.5–E13.5 leading to embryonic lethality for all
animals around E15.5 of development (Figure 6C). In contrast and
as expected from previous studies of other GATA mutants, mice
from Tg Line 8, which expressed supraphysiologic levels of
hGATA-1Rb2, were indistinguishable from wt littermate embryos.
This observation underscores the importance of studying the
phenotypic effects of mutant GATA transgenes within a
physiologic range of expression for this type of transgenic mouse
approach (see Discussion).
Flow cytometry analysis for c-Kit and TER119 expression of
liver cells from 1.05/Y+hGATA-1Rb2 male E13.5 embryos
generated from either Lines 2 or 5 showed a decrease in the
proportion of mature erythroid cells and late erythroid precursors
with concurrent increase in that of early precursors, comparatively
to wt littermate embryos (24% vs. 81%2 for TER119high c-Kitlow
and 30% vs. 8% for TER1192 c-Kithigh, respectively), indicating a
severe delay in erythroid maturation (Figure 7A). No significant
delay was observed in 1.05/Y+hGATA-1 embryos at E13.5
(unpublished data). The liver of E15.5 embryos also contained
abnormal erythroid precursors with lobulated nuclei (Figure 7B).
Staining of fetal liver sections for the proliferating cell nuclear
antigen (PCNA) revealed an increased number of mitotic cells
(Figure 7C). Red blood cells harvested from the intracardiac space
of E15.5 GATA-1Rb2 embryos showed defective erythroid
terminal differentiation illustrated by a significant proportion of
nucleated cells with defects in nuclear condensation (Figure 7D)
and a mild increase in the number of apoptotic cells (Figure 7E).
Furthermore, analysis of CD71-positive cells showed a mild
accumulation of cells in the S phase of the cell cycle (Figure 7F).
These features share striking similarities to those observed in the
fetal liver cells of pRb2/2 mice [33] and with our data obtained
with transduced G1E and GAK14 cell lines (Figures 5 and S6,
respectively).
Discussion
We have shown here that (1) direct protein–protein interaction
between GATA-1 and pRb is required for normal terminal
erythroid differentiation in vitro and in vivo, (2) in late-stage
erythroid cells from mouse fetal liver, GATA-1 associates, through
Figure 4. GATA-1, FOG-1, and pRb/E2F-2 interplay regulates proliferation. (A) Cellular proliferation of eGFP-positive NIH 3T3 cells
transduced with an ‘‘empty’’ retroviral vector (Migr) or retroviral vectors encoding hGATA-1, hGATA-1Rb2, hGATA-1V205G, or hGATA-1V205GRb2. We
verified that .90% cells were successfully transduced by each of the retroviral vectors on the basis of coexpression of eGFP from an IRES. Cell
proliferation was monitored each day for 5 d by Uptiblue. To increase legibility, curves are numbered 1 to 6 as well as represented with different
colors. (B) Same as in (A), but using the G1E cell line. Because of the lower retroviral transduction efficiency of G1E cells (,30%), we first sorted eGFP-
positive cells for each of the retroviral vectors used on the basis of coexpression of eGFP from an IRES and then verified that the sorted population
was .95% eGFP positive. To increase legibility, curves are numbered 1 to 6 as well as represented with different colors. (C) Same as in (B), but G1E
cells were transduced with a retroviral vector (Migr) that expresses GATA-1s , which comprises a deletion of the first 83 amino acids.
doi:10.1371/journal.pbio.1000123.g004
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Figure 5. GATA-1, FOG-1, and pRb/E2F-2 interplay regulates the differentiation of G1E cells. (A) GATA-1–deficient G1E cells were
transduced with either an ‘‘empty’’ retroviral vector (Migr) or one that encodes hGATA-1 or hGATA-1Rb2. Transduced G1E cells were first sorted for
eGFP expression. We verified that the sorted population was .95% eGFP positive. Cell differentiation was examined on Day 4 posttransduction by
May-Gru¨nwald-Giemsa (MGG) (top) and benzidine (bottom) staining. Proerythroblast, intermediaries, mature erythroblast, and benzidine-positive
cells are indicated as P, I, M, and B, respectively. (B) Graphic representation of benzidine-positive G1E cells after retroviral transduction (eGFP-sorted
population). The percentage of benzidine-positive cells was monitored for 5 d. (C) Erythroid differentiation of G1E cells transduced with an empty
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a LXCXE motif, with hypophosphorylated pRb engaged with
E2F-2 to form a GATA-1/pRb/E2F-2 tri-complex, (3) GATA-1
and pRb do not form a bicomplex in the absence of E2F-2, (4) the
GATA-1/pRb/E2F-2 tricomplex inhibits the proliferation of
erythroid precursors (5) the association of GATA-1 to pRb/E2F
alters G1-to-S phase progression and (6) FOG-1 is capable of
displacing pRb/E2F-2 in vitro from the GATA-1/pRb/E2F-2
tricomplex. The physiological relevance of this latter observation
needs to be further investigated.
A mechanism by which GATA-1/pRb/E2F-2 tricomplex
induces cell cycle arrest during erythroid differentiation is likely
to be, at least in part, by sequestering E2F within a complex in
which pRb is in its hypophosphorylated form. FOG-1 is able to
displace GATA-1 away from the complex, and this may then allow
Figure 6. GATA-1/pRb interaction is necessary for terminal erythropoiesis in vivo. (A) Comparative levels of GATA-1 proteins in fetal livers
of E12.5 wt or transgene-expressing mouse embryos. Top, fetal livers from one wt male (X/Y) and one wt female (X/X) E12.5 embryos as well as from
two males GATA-1.05/Y (referred to as ‘‘1.05/Y’’ in the figure) transgenic for either hGATA-1 (referred to as ‘‘wt’’ in the figure) or hGATA-1Rb2 (referred
to as ‘‘Rb2’’ in the figure). Nuclear extracts were subjected to western blot analysis using an a-GATA-1 Ab and reprobed with an anti–b-actin (a-Actin)
Ab (AC-15 clone; Sigma). Bottom, GATA-1 protein levels were quantified by chemiluminescence (Intelligent Dark box, LAS-3000, Fujifilm) and
normalized for b˜-actin protein levels (n= 3). Results are expressed as means6standard deviation (SD) of three independent experiments. (B)
Crossbreeding of XGATA-1.05/X female mice with transgenic male mice expressing hGATA-1 or the mutant hGATA-1Rb2 proteins results in four
possible genotypes with or without the transgene. Since the GATA-1 gene is located on the X chromosome, hemizygous XGATA-1.05/Y mice die in
utero. The expected (if the transgene was resulting in complete rescue) and the observed pup number of XGATA-1.05/Y mice harboring the
transgenes are indicated. (C) Top, fetal livers from E13.5 GATA-1.05/Y+hGATA-1wt control embryos (referred to as ‘‘1.05/Y+hGATA-1wt’’ in the figure)
show an indistinguishable appearance from their wt littermates (Wt), and viable pups were born with the expected Mendelian distribution. Bottom, in
contrast, GATA-1.05/Y+hGATA-1Rb2 embryos in lane 5 (referred to as ‘‘1.05/Y+GATA-1Rb2’’ in the figure) are pale comparatively to their wt littermates
(Wt) and die in utero.
doi:10.1371/journal.pbio.1000123.g006
retroviral vector (Migr) or one that expresses hGATA-1, hGATA-1Rb2, hGATA-1V205G, or hGATA-1V205GRb2 was assessed, after 6 d in culture, by flow
cytometry analysis for c-Kit, TER119, and CD71 expression. Transduced G1E cells were first sorted for eGFP expression. Panels on the left column
confirmed that sorted cells were .98% positive for eGFP expression. The x- and y-axes are indicated at the top of the panels (SSC= side scatter;
n= cell counts). For panels in the left column, TER119high and TER119low are delineated.
doi:10.1371/journal.pbio.1000123.g005
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E2F-2 to be liberated upon subsequent phosphorylation of pRb. In
parallel, the GATA-1/FOG-1 complex exerts its transcriptional
effects as part of the program of erythroid differentiation, as
exemplified by the extinction of c-Kit expression. Fine-tuning by
exogenous inducers is likely to operate, as pRb and GATA-1 are
regulated by phosphorylation [34]. This study does not yet address
the possibility that the GATA-1/pRb/E2F-2 tricomplex possesses
specific transcriptional activity in addition to the mere sequestra-
tion of E2F-2. For instance, GATA-1/pRb/E2F-2 may activate or
inhibit E2F target genes transcription by (1) displacing other pRb-
associated LXCXE proteins, (2) increasing gene transactivation
through the GATA-1 transactivator domain, (3) acting as a protein
platform for other associated GATA-1 proteins (e.g., acetyltrans-
ferase P300/CBP, PU.1, EKLF). Preliminary chromatin immu-
noprecipitation (ChIP) assays, using a GATA-1–specific Ab for
ChIP, indicate that known E2F targets genes such as Cdc6 [35]
can be detected (unpublished data). Transcriptional studies and
cDNA microarrays analysis would sort through these hypotheses,
as previously conducted for other Rb-associated proteins that
include Id2 [36].
Figure 7. Analysis of fetal hematopoiesis in 1.05/Y+hGATA-1Rb2 mice. (A) Analysis by flow cytometry of liver cells from E13.5 Wt or 1.05/
Y+hGATA-1Rb2 embryos. Cells were labeled with c-Kit and TER119 Abs, showing a decrease in the proportion of TER119+/c-Kit2mature erythroblasts
with compensatory increase in proerythroblasts and earlier erythroid precursors. (B) Liver sections from E15.5 wt or 1.05/Y+hGATA-1Rb2 embryos
stained with hematoxylin and eosin show a decrease in the number of erythroid cells (top) with evidence of abnormal erythroblasts having lobulated
nuclei at higher magnification (bottom). (C) Immunohistochemical analysis for Proliferating Cell Nuclear Antigen (PCNA) in liver sections from E12.5
wt or 1.05/Y+hGATA-1Rb2 embryos. High magnification panels (bottom) show that the proportion of PCNA-positive cells among erythroblasts is
higher in 1.05/Y+hGATA-1Rb2 embryos than in wt embryos. (D) Hematoxylin and eosin analysis of red blood cells in the intracardiac space of E15.5
embryos. (E) Immunohistochemical analysis for Terminal dUTP Nick-End Labeling (TUNEL) assay to detect apoptotic cells in liver sections from E12.5
wt or 1.05/Y+hGATA-1Rb2 embryos. (F) Cell cycle distribution in hGATA-1Rb2 mice. DNA content analysis of CD71-positive cells from livers of e12.5
wt (black line) and individual 1.05/Y+GATA-1Rb2 embryos (red, green, and blue lines). Percentages of each subpopulation of cells in G0/G1, S, and G2/
M phases are indicated.
doi:10.1371/journal.pbio.1000123.g007
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For the past several years, conflicting reports have sparked an
active debate as to whether the fatal anemia observed in Rb2/2mice
was of extrinsic (cell-nonautonomous) [16,17] and/or intrinsic (cell-
autonomous) [18,19] origin. During the revision of this manuscript,
two studies have added to our understanding of the role of pRb
during erythroid differentiation. The Walkley and Orkin laboratories
have gathered convincing evidence for a cell-type–intrinsic and cell-
autonomous role of pRb in erythropoiesis, using conditional Rb
inactivation restricted to the erythroid lineage [21]. Another study
from the Macleod laboratory has shed light on the interplay between
pRb and E2F-2 during erythropoiesis by showing that the concurrent
loss of E2F-2 and pRb is surprisingly capable of rescuing terminal
erythroid maturation to Rb null red cells [20]. With the double
mutants, erythroid precursors resume normal cycle cell arrest in S
phase and concurrent terminal erythroid maturation, although the
compensatory mechanisms remain unknown [20]. Our study brings a
molecular basis for the existence of an intrinsic component by
establishing a direct physical link between pRb/E2F-2 and the master
transcription factor of erythroid differentiation GATA-1.
Our findings also provide an explanation for the lack of full
rescue of GATA-1–deficient mice by the related factors GATA-2
and GATA-3 when expressed in lieu of GATA-1, since GATA-2
and GATA-3, which share extensive functional similarities with
GATA-1 [37], do not contain an LXCXE motif. The variable
degree of severity of the observed phenotypes between various
studies is likely to reflect the levels of expression obtained for the
GATA-2 and GATA-3 factors according to the transgenic
approach used, ranging from embryonic lethality by lack of
erythropoiesis to viability with anemia at the adult stage [32,37]. A
similar observation has been reported with other GATA-1
mutants overexpressed in the same transgenic mouse model
[38], indicating the importance of comparing GATA factors
within the same range of transgene expression levels in these
studies [39]. So is our observation with the supraphysiologic
expression level of the hGATA-1Rb2 Tg Line 8, and it is likely that
pRb-independent pathways are also affected in the case of GATA
overexpression. For instance, supraphysiologic GATA-1 expres-
sion levels may disturb the optimal GATA-1 to Gfi-1B cellular
ratio, thus deregulating the antiapoptotic Bcl-x(L) factor [40], or
alter microRNA (miRNA) levels during erythroid maturation [41].
In humans, a severe anemia has been recently described in a
family of patients with an inherited splicing mutation of the GATA-1
gene that results in exon skipping and expression of an N-terminally
deleted GATA-1 protein (GATA-1s) [23]. GATA-1s is translated
from a downstream ATG initiation codon that encodes Met84 in the
full-length GATA-1. Here, we show that this mutation disrupts the
association of GATA-1s to pRb because Met84 is located within the
LNCM84E motif, thus deleting it from the GATA-1s form.
However, our data also suggest that GATA-1s and hGATA-
1pRb2 are not functionally equivalent and, thus, that it is likely that
the N-terminal moiety of GATA-1 has an additional Rb-
independent role. hGATA-1s may thus result in a phenotype less
severe than hGATA-1pRb2 possibly because a double loss of
function may elicit a syndrome of lesser severity than a single loss, as
observed with the double-null mice E2F-22/2 pRb2/2 [20] or
Id22/2 pRb2/2 [16]. A caveat to the interpretation of these
experiments is that the mutation in the LXCXE motif may
concurrently disrupt some other critical yet unknown function of
GATA-1. These observations may also help understand the specific
pre-leukemic syndrome associated with acquired somatic GATA-1
mutations, which also result in GATA-1s expression, in patients
with the Down syndrome (trisomy 21) [24].
The interplay uncovered here between factors that regulate cell
cycle and transcription factors key to the differentiation of the red
blood cell lineage should be considered for the interpretation of
pRb, GATA-1, or FOG-1 mutant mice and corresponding
mutations associated with specific human syndromes. These
findings may also form the basis for the discovery of similar
pathways in other tissues during both ontogenesis and homeostatic
cell production throughout life.
Materials and Methods
Plasmid Construction and Retroviral Transduction
Human GATA-1Rb2 cDNA was generated by PCR and
sequenced. This cDNA was then subcloned in the retroviral vector
Migr. Human FOG-1 cDNA was subcloned in pRSVcDNA3
(Invitrogen). GATA-1V205G, GATA-1V205GRb2, and FOG-1S706R
mutants were obtained using the QuickChange Site-Directed
Mutagenesis Kit (Stratagene) with respective, previously described,
plasmids as templates. Construct sequences were confirmed by
DNA sequencing. Retroviral production and cell transduction
were performed as previously described [34]. Two days after
transduction, GFP-positive cells were sorted by flow cytometry
(Epics Altra; Beckman Coulter).
Cell Culture and Transfection
NIH-3T3 were maintained at low population doubling and
density. NIH-3T3 and SAOS-2 cells were transfected using
lipofectamine 2000 transfection reagent (Invitrogen). Uptiblue
reagent (Interchim) was used for cell proliferation assays with
fluorimetric excitation at 560 nm and reading at 590 nm
(Typhoon 9400; Amersham Bioscience). G1E cells were grown
as previously described [34]. Cytospin samples were stained with
May-Gru¨nwald-Giemsa to assess and score the various stages of
erythroid differentiation. Hemoglobinization was evidenced by
benzidine staining. Erythroid cells from mouse fetal livers were
obtained from E12.5 C57BL/C embryos.
Protein Analysis
For nuclear extract preparation, cells were washed once with
PBS and incubated for 10 min at 4uC in buffer A (10 mM HEPES
[pH 7.6], 3 mM MgCl2, 10 mM KCl, 5% glycerol, 0.5% NP-40)
containing phosphotyrosine phosphatase inhibitors (1 mM
Na2VO4), phosphoserine/threonine phosphatase inhibitors
(20 mM NaF, 1 mM sodium pyrophosphate, 25 mM b-glycero-
phosphate), and proteinase inhibitors. After centrifugation, nuclear
pellets were resuspended in buffer A containing 300 mM KCl. and
incubated for 30 min at 4uC. After centrifugation, nuclear extracts
were quantified by BCA staining (Pierce), half-diluted with buffer
A and subjected to IP using the appropriate Ab: hGATA-1 C-
terminal region epitope C-20 (Santa Cruz Biotechnology),
mGATA-1 C-terminal region epitope, M-20 (sc-1234; Santa Cruz
Biotechnology), pRb (Nu 554136; BD Pharmingen), E2F-2 (sc-633;
Santa Cruz Biotechnology), FOG-1 (sc-9361; Santa Cruz
Biotechnology), Nph (sc-6013R; Santa Cruz Biotechnology), or
with nonimmune corresponding (control) Abs, respectively,
normal goat IgG (sc-2028), normal mouse IgG (sc-2025), and
normal rabbit IgG (sc-2027) (Santa Cruz Biotechnology). Beads
were then washed five times with buffer A and resuspended in 16
Laemmli buffer. Western blot analyses were performed as
described [34] with primary Abs against GATA-1 (N1, Cat. Nu
sc-266; Santa Cruz Biotechnology), FOG-1 (M-20, Cat. Nu sc-
9361; Santa Cruz Biotechnology), pRb (Cat. Nu 554136; BD
Pharmingen; and human c-terminal pRb epitope C15, Cat. Nu sc-
50; Santa Cruz Biotechnology) or phospho-specific pRbs
(pRbPser780, pRbPser870/811, and pRbPser795 PhosphoPlus Rb
antibody Kit Cat. Nu 9300; Cell Signaling Technology).
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Generation of Transgenic Mice
Wt and mutant human GATA-1 cDNAs were cloned 39 to the
mouse GATA-1 HRD [32]. DNA fragments were purified from
vector sequences and transgenic mice generated by DNA
microinjection into fertilized BDF1 eggs using standard proce-
dures. The GATA-1.05 allele was monitored by PCR using primers
corresponding to the neomycin-resistance gene in the original
GATA-1.05 targeting vector.
PCNA Staining
Whole embryos were fixed in 4% formaldehyde solution at 4uC
for 16 h followed by embedding in paraffin. PCNA staining was
performed using a kit from Zymed Laboratories.
Flow Cytometry
Phycoerythrin-conjugated anti-mouse TER119 (TER119-PE;
BD Pharmingen, cat Nu553673), APC-conjugated anti-mouse
CD117 (c-Kit) (BD Pharmingen, cat Nu553356), biotin-conjugated
anti-mouse CD71 (BD Pharmingen, cat Nu557416) and strepta-
vidin-PE-PC5 secondary antibodies (BD Pharmingen) were used
for surface labeling of cells. Flow cytometry was performed using
FACSCalibur, and data were analyzed with the Cell Quest Pro
software.
Analysis of Cell Cycle Distribution
Cells were pelleted, fixed in 70% ethanol, and then resuspended
at a concentration of 106 cells per milliliter in PBS containing
5 mM EDTA and 5 mg/ml Hoechst 33342 (Molecular Probes–
Invitrogen). The cells were then analyzed with a LSRII cytometer
(BD Biosciences) equipped with both the DIVA and the Flowjo
8.8.3 software using the Dean-Jett-Fox algorithm.
Supporting Information
Figure S1 GATA-1 interaction with endogenous pRb and
antibody controls. (A) Human and murine GATA-1 proteins
interact with endogenous murine pRb. NIH-3T3 cells were
transduced with the ‘‘empty’’ retroviral vector (Migr) or with
retroviral vectors encoding either human (h) or murine (m)
GATA-1. We verified that .90% cells were successfully
transduced by each of the retroviral vectors on the basis of
coexpression of eGFP from an internal ribosome entry site (IRES).
IPs of GATA-1 (5 mg, a-GATA-1: M-20, sc-1234; Santa Cruz
Biotechnology) or pRb (5 mg, a-pRb, nu 554136; BD Pharmingen)
were performed with 500 mg of nuclear extract. IPs using 5 mg of
nonimmune IgG isotype of the corresponding species (normal goat
IgG sc-2028 for GATA-1 and normal mouse IgG sc-2025 for pRb;
Santa Cruz Biotechnology) were used for each transfection as
negative controls for the specificity of the precipitation and
coprecipitation obtained with each immune antibody used in the
IP and co-IP experiments. Nuclear extracts before IP (input 5%)
and bound proteins were resolved by western blot analysis using
the antibody against GATA-1 (a-GATA-1 M-20, sc-1234; Santa
Cruz Biotechnology) or pRb (a-pRb, nu 554136; BD Pharmingen)
as indicated. The horseradish peroxydase-conjugated secondary
Ab used (Affinipure goat anti-rat IgG light chain specific, 112-035-
175; Affinipure goat anti-mouse IgG light chain specific, 115-035-
175) was provided from Jackson Immunoresearch and did not
recognize reduced denaturated IgG heavy chains that comigrate at
50 kDa near GATA-1 (http://www.jacksonimmuno.com/cata-
log/CatPages/rblc.asp). These secondary Abs were used in all the
blotting assays of this paper. This experiment indicates that both
human and murine GATA-1 interact with endogenous murine
pRb with the same efficiency. (B) Control of the specificity of the
Abs utilized. NIH-3T3 cells were transfected with the ‘‘empty’’
retroviral vector (Migr) or with retroviral vectors encoding for
either hGATA-1, hGATA-1Rb2, or hGATA-1s. IP of GATA-1
(a-GATA-1 M-20, sc-1234; Santa Cruz Biotechnology) or pRb (a-
pRb; BD Pharmingen) were performed on 500 mg of nuclear
extract. Nonimmune IgG (mouse for pRb and goat for GATA-1;
Santa Cruz Biotechnology) were used as controls for each
transfection (lanes 2, 7 12, 17, and 4, 9, 14, 19, respectively).
Nuclear extracts before IP (input 5%, lane 1, 6, 11, and 16) and
bound proteins were resolved by western blot analysis using the Ab
against GATA-1 (a-GATA-1 N-1 sc-266; Santa Cruz Biotechnol-
ogy) or pRb (phospho-specific pRbs: pRbPser780, pRbPser870/
811, and pRbPser795 PhosphoPlus Rb antibody Kit Cat. Nu
9300; Cell Signaling Technology) as indicated. We thus conclude
that only wt GATA-1 can interact with pRb as shown by the
complex coprecipitated by GATA-1 antibody as well as the pRb
antibody. This interaction is specific as no complex was found in
the IgG control lane. Neither GATA-1Rb2 nor GATA-1s can
interact with pRb (even with a large amount of protein), indicating
that the LNCME motif is required for the interaction.
Found at: doi:10.1371/journal.pbio.1000067.s001 (2.13 MB TIF)
Figure S2 GATA-1 forms a complex with pRb and E2F-2
in primary erythroid cells. (A) Experimental procedures used
for (B–D). Fetal livers were dissected from C57BL/6 embryos at
embryonic day 12.5 (E12.5) and disaggregated in a-MEM
supplemented with phosphotyrosine phosphatase inhibitors
(1 mM Na2VO4; Sigma), phosphoserine/threonine phosphatase
inhibitors (20 mM NaF, 1 mM sodium pyrophosphate, 25 mM b-
glycerophosphate; Sigma), and proteinase inhibitors (Roche) to a
single-cell suspension by serial passage through a 23-ga needle,
followed by a 27-ga needle. Viability of cells was assessed by
Trypan blue staining (,0.5% of positive cells), and erythroid
differentiation stages were checked by cell surface labeling using
the following Abs: phycoerythrin-conjugated anti-mouse TER119
(TER119-PE; BD Pharmingen, cat Nu553673), APC-conjugated
anti-mouse CD117 (c-Kit; BD Pharmingen, cat Nu553356), biotin-
conjugated anti-mouse CD71 (BD Pharmingen, cat Nu557416),
and streptavidin-PEPC5 secondary antibodies (BD Pharmingen).
Flow cytometry was performed on an aliquot of 105 cells using
FACScan, and data were analyzed with the DIVA software.
Eighty-five percent to 90% of fetal liver cells were CD71+
TER119+ c-Kit2, showing a majority of cells at the late stage of
erythroid differentiation. Nuclear extract were prepared as
described in Materials and Methods except that the glycerol
concentration was 10% instead of 5% to allow for an improved
recovery of nuclear pellets. IPs were then performed on equal
amounts of nuclear extract (500 mg per point) using specific Abs or
nonimmune-related (control) Abs. Immunoprecipitated proteins
(bound, lanes 2 and 4) were analyzed by western blot (WB) as well
as a 5% fraction of nuclear extract before (input, lane 1) and after
(supernatant, lane 3 and 5) each IP. Nucleophosmin (Nph), which
does not bind to GATA-1 or pRb complexes, was used as a
negative control of the specificity of coprecipitation (lane 6). (B)
Efficiency and specificity of immunoprecipitating Abs. IPs were
performed using nuclear lysates from E12.5 fetal livers using
specific Abs against GATA-1 (sc-1233; Santa Cruz Biotechnology),
pRb (554136; BD Pharmingen), E2F-2 (sc-633; Santa Cruz
Biotechnology), FOG-1 (sc-9361; Santa Cruz Biotechnology),
and Nph (sc-6013R; Santa Cruz Biotechnology), or with
nonimmune corresponding (control) Abs, respectively, normal
goat IgG (sc-2028), normal mouse IgG (sc-2025), and normal
rabbit IgG (sc-2027) (Santa Cruz Biotechnology). Proteins were
analyzed by western blot using the same Abs (except for GATA-1,
where the sc-266 from Santa Cruz Biotechnology was used). As
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expected, all the proteins were totally immunodepleted from the
nuclear extracts, and no signal was detected in the supernatants
after each IP (lane 4 versus 5). This depletion thus demonstrates
specific antigen–Ab interactions, since no protein is immunopre-
cipitated by the related control Ab (lane 2) or by a nonspecific Ab
(Nph, lane 6). (C) Identification of GATA-1 complexes in fetal
liver erythroid cells and relevant Ab controls in co-IP assays. Co-
IPs were performed using nuclear lysates from E12.5 fetal livers, as
described in (A). The first step of IP was performed with either a
specific Ab directed against GATA-1 (sc-1233; Santa Cruz
Biotechnology), a nonimmune corresponding Ab (control Ab:
normal goat IgG sc-2028), or nonspecific anti-Nph Ab. Copreci-
pitated proteins were then analyzed by western blot using the same
Abs as in (B), referred at the left-hand side of the figure. None of
the proteins studied is unspecifically coprecipitated with the
nonimmune idiotype (lane 2) or a nonspecific antibody (lane 6)
even in the presence of a large amount of proteins. As expected,
FOG-1, a known partner of GATA-1, is coprecipitated and serves
as a positive control (lane 4). Endogenous pRb and E2F2 are also
copurified with GATA-1 in a specific manner (lanes 4b and 4c).
Note that a small portion of each fraction remains unassociated
with GATA-1, corresponding to free proteins or to distinct
complexes that exclude GATA-1 (lane 5). (D) Identification of
E2F2 complexes in fetal liver erythroid cells and relevant Ab
controls in co-IP assays. Same as in (C), except that the first step of
IP was performed with either a specific Ab directed against E2F-2
(sc-633; Santa Cruz Biotechnology), a nonimmune corresponding
Ab (control Ab: normal rabbit IgG sc-2027), or nonspecific anti-
Nph Ab. As obtained in (C), pRb, the E2F-2 known partner, is
copurified by E2F-2 immunodepletion (lane 4b), and we show that
GATA-1 is also coprecipitated (lane 4a). These observations allow
us to propose the existence of a ternary complex containing pRb,
GATA-1, and E2F-2. This complex excludes FOG-1: no FOG-1
protein is observed in lane 4d, and the totality of FOG-1 is
recovered in the supernatant (lane 5d versus lane 3d). As a faint
amount of GATA-1 and pRb remain in the supernatant (lane 5a),
this experiment cannot in and of itself exclude the possibility that
GATA-1 and pRb can form a binary complex without E2F-2. The
convincing evidence that GATA-1 and pRb do not form a
bicomplex in the absence of E2F-2 is provided in Figure 1D. (E)
Experimental procedure of Figure 1D.
Found at: doi:10.1371/journal.pbio.1000067.s002 (3.13 MB TIF)
Figure S3 hGATA-1 and hGATA-1Rb2 proteins have
undistinguishable transcriptional activity. To assess the
respective transcriptional activities of hGATA-1, hGATA-1Rb2,
and hGATA-1s, we performed transient transfection assays in
NIH-3T3 cells using a luciferase reporter gene driven by several
minimal erythroid-specific promoters that included (1) the
erythroid porphobilinogene deaminase promoter (nucleotides
2714 to +78 PBGD) [42], (2) the glycophorin-B promoter
(295GpB) [43], (3) the erythropoietin receptor promoter (258,
+43 Epo-R) [44], (4) the 3XGATA-TK synthetic promoter [45],
and (5) the GATA-1 proximal promoter (IE) together with its
upstream enhancer element (IE3.9int) [46]. These different
plasmids were cotransfected with the ‘‘empty’’ Migr plasmid or
with Migr-derived plasmids expressing hGATA-1, hGATA-1Rb2,
or hGATA-1s. Firefly luciferase activity was measured according
to the manufacturer’s instructions (Dual Luciferase Reporter Assay
System; Promega), and individual transfections were normalized
by quantification of Renilla luciferase activity (pRL-TK; Pro-
mega). The total amount of DNA was kept constant at 700 ng in
each transfection (500 ng of expression plasmid, 100 ng of
reporter plasmid, and 100 ng of pRL-TK plasmid per well of a
24-well plate). Luciferase activity was determined 24 h after
transfection. Data are expressed as relative luciferase activity
(RLu). Results are the means6standard error of the mean (SEM)
of three independent experiments. No difference in the transcrip-
tional activity of hGATA-1 and hGATA-1Rb2 was detected with
these promoters. With respect to hGATA-1s, the Epo-R minimal
erythroid (pEpoR) and the GATA-1 (IE3.9int) promoters were
activated at a lower level (approximately 50%), whereas the
erythroid porphobilinogene deaminase promoter was not activat-
ed, and both the glycophorin-B (295GpB) and the synthetic
3XGATA-TK promoters were equally transactivated.
Found at: doi:10.1371/journal.pbio.1000067.s003 (1.07 MB TIF)
Figure S4 Comparison of the two different methods
used to monitor cell proliferation. Retroviral vectors
encoding hGATA-1 or the hGATA-1 mutant that cannot interact
with pRb (hGATA-1Rb2) were used to transduce NIH-3T3 cells
(100% eGFP-positive cells). Proliferation of the transduced NIH-
3T3 cells was monitored each day for 5 d. For cell growth analysis,
identical numbers of NIH-3T3 cells transduced with retroviral
vectors expressing hGATA-1 or hGATA-1Rb2 were plated on
Day 1. (A) At each indicated day, the number of viable cells was
determined by trypan blue dye exclusion (n=3). Mock indicates
the ‘‘empty’’ Migr retroviral transduction. (B) Representative
growth curve obtained by using the fluorimetric metabolic growth
indicator Uptiblue reagent (n=3). (C) Comparison of the analysis
obtained with the two methods used in (A) and (B): each data point
obtained in (A) was converted into a percentage of cell numbers
comparatively to the initial number of cells at Day 0 (top). Each
data point obtained in (B) was converted into a percentage of the
590-nm fluorescence in arbitrary units comparatively to that
measured at Day 0 (bottom). The resulting curves and the R2
values were determined by the Excel software (Microsoft). The
observation that the deduced R2 curves are of identical value
indicates that the two methodologies are comparable. The
proliferation of NIH-3T3 cells can be thus monitored by either
trypan blue dye exclusion or Uptiblue reagent.
Found at: doi:10.1371/journal.pbio.1000067.s004 (1.78 MB TIF)
Figure S5 GATA-1/pRb interaction is required for
GATA-1–mediated arrest of cell proliferation. (A) Same
as in Figure 3A, except that the hGATA-1Rb2 retrovirus was not
used here and that proliferation was monitored in the presence of
a siRNA directed against endogenous pRb. The siRNA was
transfected at Day 0 of the experiment (n=4). (B) Retroviral
vectors expressing hGATA-1 or hGATA-1Rb2 were used to
transduce NIH-3T3 cells in the absence (2) or in the presence (+)
of an siRNA directed against endogenous pRb (sc-29469; Santa
Cruz Biotechnology). pRb knock-down analysis was performed
each day for three consecutive days. Total proteins were subjected
to western blot analysis using an anti-pRb antibody (BD
Pharmingen). (C) Membranes were then stripped and reprobed
with an anti-p107 antibody (sc 318; Santa Cruz Biotechnology).
These data indicate that pRb protein levels were very low shortly
after transfection of the siRNA directed against pRb and started to
increase 3 d thereafter. The level of pRb expression at Day 3
correlates with the decrease in cell proliferation observed the same
day with NIH-3T3 cells transduced with a retroviral vector
expressing hGATA-1 and transfected with the pRb siRNA [see
(A)]. (D) The same retroviral vectors as in (A) were used to
transduce the human cell line SAOS-2, which expresses neither
GATA-1 nor pRb endogenously. Cell proliferation was monitored
each day for 4 d with the Uptiblue reagent (n=6). We verified that
.90% cells were successfully transduced by each of the retroviral
vectors on the basis of coexpression of eGFP from an IRES.
Found at: doi:10.1371/journal.pbio.1000067.s005 (5.01 MB TIF)
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Figure S6 GATA-1/pRb interaction is necessary for
GATA-1–mediated terminal erythroid differentiation of
GAK14. (A) The erythroid cell line GAK14 cells, which is
defective in GATA-1 as it derives from GATA-1.05 ES cells (M.
Yamamoto, unpublished data) were grown on OP9 stromal cells in
the presence of erythropoietin and stem cell factor. GAK14 cells
were transduced with retroviral vectors expressing hGATA-1 or
hGATA-1Rb2. Differentiation of the cells was studied at Day 7
posttransduction by May- Gru¨nwald-Giemsa staining. (B) Retro-
virally transduced GAK14 cells were analyzed by microscopy and
the distribution of cells at distinct stages of erythroid differentiation
scored. More than 300 cells were examined for each sample.
Expression of hGATA-1Rb2 did not impair the initiation of
erythroid differentiation but dramatically alter the distribution of
erythroid precursors towards the more immature elements. These
results indicate that GATA-1/pRb interaction modulates the
proportion of the various erythroid precursors. Baso, basophilic
erythroblasts I and II; Ortho, orthochromatophilic erythroblasts;
Poly, polychromatophilic erythroblasts; Pro, proerythroblasts.
Found at: doi:10.1371/journal.pbio.1000067.s006 (3.02 MB TIF)
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